APA citiranje

Ali, S., Banerjee, S., Schaffert, J. M., El-Rayes, B. F., Philip, P. A., & Sarkar, F. H. (2010). Concurrent Inhibition of NF-κB, Cyclooxygenase-2, and Epidermal Growth Factor Receptor Leads to Greater Anti-Tumor Activity in Pancreatic Cancer.

Citação norma Chicago

Ali, Shadan, Sanjeev Banerjee, Jacqueline M. Schaffert, Bassel F. El-Rayes, Philip A. Philip, and Fazlul H. Sarkar. Concurrent Inhibition of NF-κB, Cyclooxygenase-2, and Epidermal Growth Factor Receptor Leads to Greater Anti-Tumor Activity in Pancreatic Cancer. 2010.

MLA citiranje

Ali, Shadan, et al. Concurrent Inhibition of NF-κB, Cyclooxygenase-2, and Epidermal Growth Factor Receptor Leads to Greater Anti-Tumor Activity in Pancreatic Cancer. 2010.